Amgen completes $27.8b acquisition of Horizon Therapeutics
Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two.
Drugs
Health
Pharma
Drugs
Pharma
Pfizer to invest $1.26 billion in Belgium plant in European expansion plan
Pfizer Inc. plans to invest 1.2 billion euros (($1.26 billion) in its plant in Belgium over the next three years to expand in.